Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Looking Into Biogen's Recent Short Interest
Tickers BIIB
Tags Benzinga BIIB Short Sellers
From Benzinga
1 Unstoppable Growth Stock Heading to $2 Trillion by 2030
Tickers BIIB LLY
Tags LLY BIIB Recent Press Releases
From Motley Fool
Biogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate
Tickers BIIB NEWS SAGE
Tags SAGE General Health Care
From Benzinga
Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial
Tickers BIIB NEWS UCBJF UCBJY
Tags Benzinga UCBJY Market News
From Benzinga
Forecasting The Future: 20 Analyst Projections For Biogen
Tickers BIIB
Tags BZI/AAR Benzinga BIIB
From Benzinga
Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
Tickers BIIB LLY NEWS NVDA
Tags Lucas Montarce Markets NVDA
From Benzinga
Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
Tickers BIIB BMY NEWS
Tags News Sanders General
From Benzinga
Biogen/Eisai's Leqembi Brings Hope To Early Alzheimer's Patients Amid Logistical Challenges
Tickers BIIB ESALY NEWS
Tags Market News Benzinga Biotech
From Benzinga
Biogen's Higher Dose Spinraza Shows To Slow Neurodegeneration Faster In Infants With Rare Neuromuscular Disorder
Tickers BIIB NEWS
Tags BIIB Health Care General
From Benzinga
Key Takeaways From Biogen Analyst Ratings
Tickers BIIB
Tags BIIB Benzinga BZI/AAR
From Benzinga
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now
Tickers BIIB LLY NVO
Tags Market News NVO LLY
From Motley Fool
Eli Lilly Is The Nvidia Of Weight Loss And GLP-1 Space, Says Roundhill Investments CEO, Emphasizes Market Leadership And Growth Potential Of Zepbound Maker
Tickers BIIB LLY NEWS NVDA
Tags NVO LLY Benzinga
From Benzinga
Chinese E-Commerce Giant Drops 35% In 2 Days, But Analysts See 92% Upside Potential
Tickers ASIA BIIB DCOM DLTR
Tags MU Stories That Matter Top Stories
From Benzinga
Eli Lilly's Alzheimer's Drug Faces UK Agency Block After Biogen's Medicine Rejection Over Cost, Safety
Tickers BIIB LLY NEWS
Tags General News Briefs
From Benzinga
Biogen's Alzheimer's Drug Secures UK Approval, But An Independent Agency Does Not Recommend Reimbursement
Tickers BIIB ESAIY ESALF NEWS
Tags General Briefs News
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Biogen
Tickers BIIB
Tags Market News Analyst Ratings Benzinga
From Benzinga
A Blood Test Could Detect Early Alzheimer's. That Could Make These 2 Stocks Red-Hot Buys.
Tickers BIIB LLY
Tags LLY ESAI/Y Recent Press Releases
From Motley Fool
How Is The Market Feeling About Biogen?
Tickers BIIB
Tags BIIB Benzinga Trading Ideas
From Benzinga
Biogen (BIIB) Q2 2024 Earnings Call Transcript
Tickers BIIB
Tags BIIB Recent Press Releases Market News
From Motley Fool
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
Tickers AAPL AIG AMZN ARM
Tags MBLY SQ BUD
From Benzinga
Biogen Q2 Earnings: Beats Consensus, Lifts 2024 Profit Forecast As New Drug Launches Expected To Offset Decline In Multiple Sclerosis Med Sales
Tickers BIIB NEWS
Tags Top Stories Guidance Stories That Matter
From Benzinga
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
Tickers AAPL AMZN ARM BBAI
Tags SQ BUD MBLY
From Benzinga
The Analyst Verdict: Biogen In The Eyes Of 12 Experts
Tickers BIIB
Tags Benzinga BIIB BZI/AAR
From Benzinga
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
Tickers AAPL ADM AEP AIG
Tags MDLZ CNK CHK
From Benzinga
Europe Just Turned Down Biogen's Alzheimer's Drug. Is the Stock One to Avoid, or a Bad News Buy?
Tickers BIIB ESALY
Tags Recent Press Releases BIIB ESALY
From Motley Fool
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Tickers ADN AEYE AON ATUS
Tags Intraday Update SDST GROM
From Benzinga
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
Tickers BIIB ESALF ESALY LLY
Tags Top Stories Stories That Matter ESALF
From Benzinga
Sage, Biogen Shelve Development Of Nervous System Disorder Drug After Data Disappoints
Tickers BIIB NEWS SAGE
Tags Benzinga Trading Ideas Market News
From Benzinga
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
Tickers ALNY AZN BIIB IONS
Tags ALNY General IONS
From Benzinga
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Tickers BIIB BMY ESALF JNJ
Tags Market News MRK medicare
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.